Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor

Saskia B. Wortmann, Johan L. K. Van Hove, Terry G. J. Derks, Nathalie Chevalier, Vijaya Knight, Andreas Koller, Esmee Oussoren, Johannes A. Mayr, Francjan J. van Spronsen, Florian B. Lagler, Sommer Gaughan, Emile Van Schaftingen, Maria Veiga-da-Cunha

Blood (2020) 136 (9): 1033–1043.

https://doi.org/10.1182/blood.2019004465

Published: 2020

Includes: Supplemental data

Journal Articles

JAK2 -mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms

Blood (2019) 134 (21): 1832–1846.

https://doi.org/10.1182/blood.2019000162

Published: 2019

Includes: Supplemental data

Journal Articles

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas

Neha Mehta-Shah, MD, Peter A. Riedell, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Brad S. Kahl, MD, Todd A Fehniger, MD PhD, Chaz Moreno, Jingxia Liu, MS, PhD, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 1550.

https://doi.org/10.1182/blood-2019-124185

Published: 2019

Journal Articles

A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients with Suboptimal Metabolites Successfully Corrected with Allopurinol

Lauren Marie Vasta, MD, Richard C Zanetti, MD, Dina S. Parekh, MD, Anne B. Warwick, MD MPH, Kenneth Lieuw, MD PhD

Blood (2019) 134 (Supplement_1): 3878.

https://doi.org/10.1182/blood-2019-126184

Published: 2019

Journal Articles

Long-Term Outcomes for G-CSF Treatment of Patients with Glycogen-Storage Disease Type Ib

David Dale, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, David A. Weinstein, MD MMSc, Cornelia Zeidler, Karl Welte

Blood (2017) 130 (Supplement 1): 996.

https://doi.org/10.1182/blood.V130.Suppl_1.996.996

Published: 2017

Journal Articles

Metabolic and Endocrin Complications of Pediatric, Adolescent and Young Adult Acute Lymphoblastic Leukemia: Single Centre Experience

Bulent Zulfikar, Prof, Basak Koc, MD, Pınar Ozturk, MD

Blood (2017) 130 (Supplement 1): 5009.

https://doi.org/10.1182/blood.V130.Suppl_1.5009.5009

Published: 2017

Journal Articles

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Shahla Bari, MD, Marina Rabinovich, PharmD, BCPS, Marjorie Curry, PharmD, BCOP, Sanjay Raj Jain, MD PhD, Lorraine Cafuir, MD

Blood (2017) 130 (Supplement 1): 4926.

https://doi.org/10.1182/blood.V130.Suppl_1.4926.4926

Published: 2017

Journal Articles

Phosphatidylserine on Blood Cells and Microparticles Contributes to the Hyper-Coagulable State in Diabetic Kidney Disease

Muxin Yu, PhD, Rujuan Xie, MDPhD, Muhua Cao, MD, Yan Zhang, MD, Hui Liang, MD, Baorong Li, MD, Yingmiao Liu, MD, Li Hou, MD, Junjie Kou, MD PhD, Yayan Bi, MD PhD, Jialan Shi, MD PhD

Blood (2017) 130 (Supplement 1): 2376.

https://doi.org/10.1182/blood.V130.Suppl_1.2376.2376

Published: 2017

Journal Articles

Malyglycemia Is Associated with Increased Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients

Jenna Sopfe, MD, Amy Keating, MD, Laura Pyle, PhD, Arthur K Liu, MD, Paul Wadwa, MD, Roger Giller, MD, Gregory Forlenza, MD MS, Michael R Verneris, MD

Blood (2017) 130 (Supplement 1): 3243.

https://doi.org/10.1182/blood.V130.Suppl_1.3243.3243

Published: 2017

Journal Articles

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

Marta Mancarella, MD, Diletta Maira, MD, Valeria Ferla, Marco Capecchi, MD, Irene Motta, MD, Elena Cassinerio, MD, Alessia Marcon, MD, Marina Baldini, MD, Maria Domenica Cappellini, MD

Blood (2016) 128 (22): 4830.

https://doi.org/10.1182/blood.V128.22.4830.4830

Published: 2016

Journal Articles

Long-Term Iron Chelation Therapy with Deferiprone in Patients with Thalassemia Major and Low Iron Load

Shahina Daar, MD, Murtadha K. Al-Khabori, BSc, MD FRCPC, ABIM, M.Sc, CIP, Khalil Al Farsi, Bader Abdulla Al-Rawahi, MD, Arwa Z. Al-Riyami, BSc,MD FRCPC

Blood (2016) 128 (22): 3626.

https://doi.org/10.1182/blood.V128.22.3626.3626

Published: 2016

Journal Articles

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Hirohiko Shibayama, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tomohiko Kamimura, MD PhD, Kentaro Fukushima, MD PhD, Yutaka Imamura, MD PhD, Tetsuya Eto, MD PhD, Kazutaka Sunami, MD PhD, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2016) 128 (22): 1914.

https://doi.org/10.1182/blood.V128.22.1914.1914

Published: 2016

Journal Articles

Adrenal Suppression in Pediatric Patients during Treatment for Acute Lymphoblastic Leukemia

Mary-Pat Schlosser, BSc(Hons), MD, Daniel Burd, Alexandra Ahmet, MD FRCPC, Sarah Lawrence, MD FRCPC, Mylene Bassal, MDM

Blood (2015) 126 (23): 4863.

https://doi.org/10.1182/blood.V126.23.4863.4863

Published: 2015

Journal Articles

Inhibition of Hedgehog Signaling for the Treatment of Lymphoma and CLL: A Phase II Study from the Lysa

Roch Houot, MD PhD, Carole Soussain, MD, Hervé Tilly, MD PhD, Corinne Haioun, MD PhD, Catherine Thieblemont, Olivier Casasnovas, MD, Krimo Bouabdallah, MD, Franck Morschhauser, MD, Steven Le Gouill, MD PhD, Gilles A. Salles, MD PhD, Tony Marchand, MD, Céline Pangault, PharmD PhD, Camille Laurent, Thierry Lamy, MD PhD

Blood (2015) 126 (23): 3970.

https://doi.org/10.1182/blood.V126.23.3970.3970

Published: 2015

Journal Articles

Neutropenia In Glycogen Storage Disease 1b (GSD1b)

David C. Dale, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Merideth L. Kelley, MS, BS, Lan Phan, BA, Laurence A. Boxer, MD, Priya S. Kishnani, MD, MB, Joanne Kurtzberg, MD, David A. Weinstein, MD, MMSc

Blood (2013) 122 (21): 2265.

https://doi.org/10.1182/blood.V122.21.2265.2265

Published: 2013

Journal Articles

Phase Ib Study Of Combination Epigenetic Therapy With 5-Azacitidine and Vorinostat In Patients With Relapsed Or Refractory DLBCL

Tiffany Tang, MD, Peter Martin, MD, Rebecca L. Elstrom, MD, Jia Ruan, MD, PhD, Richard R. Furman, MD, Arcania Garcia, June Greenberg, RN, Amelyn Rodriguez, RN, Alison Bender, PA-C, Jessica Lewis, PA-C, Ari Melnick, MD, Leandro Cerchietti, MD, John P. Leonard, M.D.

Blood (2013) 122 (21): 4339.

https://doi.org/10.1182/blood.V122.21.4339.4339

Published: 2013

Journal Articles

SCT for Secondary AML in a Patient with Glycogen Storage Disease Type 1b

Cornelia Zeidler, MD, Kinan Kafa, Martin G. Sauer, MD, Britta Maecker-Kolhoff, Johann Greil, MD, Karl Welte, MD, Christian P Kratz, MD, Karl-Walter Sykora

Blood (2012) 120 (21): 4402.

https://doi.org/10.1182/blood.V120.21.4402.4402

Published: 2012

Journal Articles

Safety and Efficacy of Frontline Nilotinib (Nb) for Chronic Phase (CP) Chronic Myeloid Leukemia (CML) in Diabetic Patients (pts)

Mahran Shoukier, Hagop M. Kantarjian, Elias Jabbour, Alfonso Quintas-Cardama, Zeev Estrov, Tapan Kadia, Gautam Borthakur, Guillermo Garcia-Manero, Steven M. Kornblau, Elizabeth M Burton, Susan O'Brien, Jorge E Cortes

Blood (2011) 118 (21): 2764.

https://doi.org/10.1182/blood.V118.21.2764.2764

Published: 2011

Journal Articles

Unraveling Early Mortality In Patients with AL Amyloidosis

Cheng E. Chee, MD, Vincent Rajkumar, PhD, Morie Gertz, Martha Lacy, MD, Steven Zeldenrust, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MB, CHB, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 4990.

https://doi.org/10.1182/blood.V116.21.4990.4990

Published: 2010

Journal Articles

Effect of the Tyrosine Kinase Inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) On Blood Glucose Levels in Diabetic and Non-Diabetic Patients.

Nicole M. Agostino, DO, Vernon M Chinchilli, PhD, Anita Koszyk-Szewczyk, MD, Rebecca Gingrich, RN, MS, OSN, Jeff Sivik, PharmD, Joseph Drabick, MD

Blood (2009) 114 (22): 4265.

https://doi.org/10.1182/blood.V114.22.4265.4265

Published: 2009

NARROW

Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor

JAK2 -mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas

A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients with Suboptimal Metabolites Successfully Corrected with Allopurinol

Long-Term Outcomes for G-CSF Treatment of Patients with Glycogen-Storage Disease Type Ib

Metabolic and Endocrin Complications of Pediatric, Adolescent and Young Adult Acute Lymphoblastic Leukemia: Single Centre Experience

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Phosphatidylserine on Blood Cells and Microparticles Contributes to the Hyper-Coagulable State in Diabetic Kidney Disease

Malyglycemia Is Associated with Increased Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

Long-Term Iron Chelation Therapy with Deferiprone in Patients with Thalassemia Major and Low Iron Load

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Adrenal Suppression in Pediatric Patients during Treatment for Acute Lymphoblastic Leukemia

Inhibition of Hedgehog Signaling for the Treatment of Lymphoma and CLL: A Phase II Study from the Lysa

Neutropenia In Glycogen Storage Disease 1b (GSD1b)

Phase Ib Study Of Combination Epigenetic Therapy With 5-Azacitidine and Vorinostat In Patients With Relapsed Or Refractory DLBCL

SCT for Secondary AML in a Patient with Glycogen Storage Disease Type 1b

Safety and Efficacy of Frontline Nilotinib (Nb) for Chronic Phase (CP) Chronic Myeloid Leukemia (CML) in Diabetic Patients (pts)

Unraveling Early Mortality In Patients with AL Amyloidosis

Effect of the Tyrosine Kinase Inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) On Blood Glucose Levels in Diabetic and Non-Diabetic Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only